3D Cell Culture Market - By Type (Scaffold-based 3D Cell Cultures, Scaffold-free 3D Cell Cultures, Bioreactors, Microfluidic 3D Cell Culture) By Application (Cancer, Stem Cell Research, Drug Discovery & Toxicology Testing), By End-use & Forecast, 2032

3D Cell Culture Market Size

3D Cell Culture Market size exceeded more than USD 1.5 billion in 2022 and is projected to witness 14.3% CAGR during 2023-2032. Rising preference for efficient and affordable drug discovery methods to drive industry expansion.
 

The surging emphasis on developing alternatives to animal testing will influence the expansion for 3D cell cultures. In recent years, most industries are working on the development of new platforms, such as innovative human 3D tissue-engineered models for replacing animal and flask cell-culture models. The increasing usage of organs-on-a-chip (OoCs) as an alternative candidate for drug screening and cell experiments will also anchor the market growth.|
 

The escalating costs associated with cell biology research may act as a significant restraint for the 3D cell culture market progress. This is mainly due to the tremendous inefficiencies incurred during the R&D activities. It has been estimated that scientists in the U.S. spend $28 billion per year on basic biomedical research that is not repeated successfully. The growing costs of biology lab equipment will also limit the rise for 3D cell cultures.
 

3D Cell Culture Market Analysis

3D cell culture market from Scaffold-based segment will exceed USD 3 billion by 2032. The expansion can be attributed to the increasing dominance of scaffolds in cell therapy and drug discovery applications. The growing burden of various chronic conditions, including cardiovascular diseases and cancer will further contribute to the adoption of scaffold-based 3D cell cultures.
 

3D cell culture market from the cancer application segment is likely hit USD 2.3 billion by 2032. 3D systems are increasingly deployed in cancer research as they facilitate efficacy testing, safety, and fundamental research. 3D cell culture models help in replicating the natural tumor architecture to provide an external proliferating zone, as well as nutrient and progression factor distribution. Increasing application in therapeutic fields, mainly in applications involving precision medicine will fuel to the market statistics.
 

North America registered 46.5% of the 3D cell culture market share in 2022 on account of the rising number of universities and research organisations in the region. The growing government initiatives and funding for the development of advanced 3D culture models will also bolster the regional business scenario. For instance, in March 2023, ALS Society of Canada (ALS Canada) joined forces with Brain Canada for investing $1.4 million to support 9 projects on cutting-edge discoveries as well as treatments for amyotrophic lateral sclerosis (ALS).
 

3D Cell Culture Market Share

Some of the prominent 3D cell culture industry players include :

• CN Bio Innovations
• Corning Incorporated
• BiomimX SRL
• Hurel Corporation
• Merck KGaA
• InSphero AG,
• Lonza AG
• MIMETAS BV
• Nortis Inc.
• Promocell GmbH
• Sartorius AG
• Becton
• Dickinson 
• Company
• Thermo Fisher Scientific Inc.
   

3D Cell Culture Industry News

• Avantor, in June 2022, partnered with GeminiBio, a leading chemical reagents and biological products supplier. The collaboration helped both the companies in meeting the rising demand for bioproduction workflow solutions.
   

The 3D cell culture market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

By Type

• Scaffold-based 3D Cell Cultures
  • Hydrogels / ECM Analogs
  • Polymeric Scaffolds
  • Micro-patterned Surface Microplates
  • Nanofiber-based Scaffolds
• Scaffold-free 3D Cell Cultures
  • Hanging Drop Microplates
  • Spheroid Microplates with ULA coating
  • Magnetic Levitation & 3D Bioprinting
  • 3D Petri Dishes
• Bioreactors
• Microfluidic 3D Cell Culture

By Application

• Cancer
• Stem Cell Research
• Drug Discovery & Toxicology Testing
• Tissue Engineering & Regenerative Medicine
• Other Applications

By End-use

• Biotechnology and Pharmaceutical Industries
• Research Laboratories and Institutes
• Hospitals and Diagnostic Centers
• Other End Uses

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Poland
  • Switzerland
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Indonesia
  • Thailand
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Peru
  • Rest of Latin America
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Iraq
  • Israel
  • Rest of Middle East & Africa